MARKETWIRE.NET

Decode Your Next Market Move

A New Study Provides Fresh Insights Into Key Trends that Will Keep the Allergy Diagnostics Market Moving Into 2027

The global market for Allergy Diagnostics is projected to reach US$6.4 billion by 2025, driven by the rise in allergies across all age groups.

Global Industry Analysts, Inc. (GIA) launches comprehensive analysis of industry segments, market trends, growth drivers, market share, size and demand forecasts on the global Allergy Diagnostics market. Report segmentation include Allergens (Inhaled Allergens, Food Allergens, Drug Allergens, Other Allergens); Product (Assay Kits, Instruments, Services); and End-Use (Hospital, Diagnostic Laboratory), Other End-Uses).

10 June 3:28 A.M., California/Marketwire/ - According to the new market research report, the global market for Allergy Diagnostics is projected to reach US$6.4 billion by 2025, driven by the rise in allergies across all age groups. The market is expected to decline in the year 2020 before recovering to reach a revised market size and reset to a new normal which going forwards in a post COVID-19 era will be continuously redefined and redesigned.

Several reasons have been theorized for this rise including global warming. The rise in temperatures is extending the growing season for plants resulting in increased pollen in the air, a chief cause for respiratory allergies. Hygiene hypothesis is presented as another reason where excessive focus on cleanliness and increased use of sanitizers and disinfectants is reducing exposure to bacteria and viruses which in reality is vital in training the immune system to fight infections. The result is the development of an immune system untaught by infections and parasites to recognize real threats. Children and adults therefore tend to develop hyperactive immune systems incapable of differentiating harmless substances from the harmful substances. Food allergies especially in children has doubled and one the reasons is the overuse of antibiotics and other drugs that reduce acid production in the stomach. This alters the behavior and function of the gastrointestinal tract inducing allergic reactions to food. Also, delayed introduction of certain foods in babies is also a key factor for developing food allergies later in life. Studies have revealed that over 25% of toddlers not introduced to peanuts in their diet go on to develop peanut allergy.

Few of the common food allergies include eggs, tree nuts, peanuts, shellfish, wheat, soy, fish, among others. Vitamin D hypothesis associates deficiency or hypovitaminosis D with increased asthma and allergic rhinitis prevalence. New studies are revealing insights into the pleiotropic effects of vitamin D. Vitamin D is increasingly being recognized as an immunomodulator and its supplementation is gaining prominence in the treatment of allergic diseases. The most interesting of the reasons put forward for the prevalence of allergies is the hidden Neanderthal DNA present in modern humans. Inter-species breeding between modern humans and ape-like species called the Neanderthals and Denisovans about 50,000 years ago is believed to be responsible for our susceptibility to allergies by influencing the genetic diversity in present-day immunity genes belonging to the human Toll-like-receptor (TLRs) family. All humans today carry trace amounts of Neanderthal DNA in the range of 1% to 6%.

Whatever maybe the reason for the rise in allergies, the scenario is throwing the spotlight on the state of allergy care worldwide, which continues to be chronically under-resourced, under-supplied with high unmet diagnostic and treatment needs. Allergy diagnostics and treatment are therefore expected to witness robust untapped potential for growth with the need of the hour being a holistic integrated approach to allergy management. The robust commercial rewards, in this space, will induce more intensive R&D for the development of non-invasive, painless, needle free allergy testing and screening methods. While the skin prick test remains popular and widespread, companies are developing innovative pain and scar-free alternatives such as single drop blood tests. The mast cell activation test (MAT) which uses blood (serum) is an example in this space. Rising in prominence is "molecular allergology" aimed at more accurately identifying and managing IgE-mediated allergic reactions and disorders like allergic respiratory diseases, food allergies, and anaphylaxis. Growth in the market hinges on the progress made in quantifying and benchmarking specific IgE responsible for the allergy. Specific IgE testing has the benefit of providing valuable diagnostic and prognostic information on serious allergies. AllerGenis LLC has broken new grounds in the long-stagnant allergy diagnostics market with its proprietary Luminex's bead-based xMAP technology capable of isolating allergenic proteins into smaller peptides called epitopes for easy identification.

Key Competitors Covered in the Report
Alk-Abello A/S
Allergy Therapeutics PLC
Angsana Molecular & Diagnostics Laboratory Pte. Ltd.
Astra Biotech Gmbh
biomerieux SA
Danaher Corporation
Demeditec Diagnostics GmbH
EUROIMMUN AG
GA Generic Assays GmbH
Hitachi Chemical Co. Ltd.
INDOOR Biotechnologies Inc.
Lincoln Diagnostics Inc.
Omega Diagnostics Group Plc
R-Biopharm Ag
Roxall Medizin GmbH
Stallergenes Greer
Siemens Healthineers
Tecan Trading AG
Theradiag
Thermo Fisher Scientific Inc.

Geographies Analyzed in the Report
USA
Canada
Japan
China
Europe (France, Germany, Italy, United Kingdom, Spain, Russia, and Rest of Europe)
Asia-Pacific (Australia, India, South Korea, and Rest of Asia-Pacific)
Latin America (Argentina, Brazil, Mexico, and Rest of Latin America)
Middle East (Iran, Israel, Saudi Arabia, United Arab Emirates, and Rest of Middle East)
Africa

More details

Research Methodology
This latest edition of the research study is conducted and published by Global Industry Analysts, Inc., in close collaboration with senior executives in the industry driving strategy, business development, marketing, sales, product management, technology and operations. All analysis and findings published in the report are based on validated engagements from a total executive pool size of 14672. Among this pool, 1762 direct interactions with domain experts were carried out via our proprietary market research platform, MarketGlass. Among the 442 unique participations, a total of 199 validated responses were received as part of this report's primary research outreach program. We are unique in the industry to provide our clients with the validated list executive engagements and the complete project data stack.

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) (www.strategyr.com) is the world's only influencer driven AI powered market research company. Serving more than 41,000 clients from 36 countries, GIA is recognized for accurate forecasting of markets and industries for 33 years, offering the widest coverage of topics, geographic markets, competitive brands, and companies profiled.

Contact Us:
Zak Ali
Director, Corporate Communications
Global Industry Analysts, Inc.
Phone: 1-408-528-9966
Email: sales@StrategyR.com